🇺🇸 AI just cloned all of Adobe’s main apps and is giving them away…FOR FREE
Atlanta developer Brandon Thomas rebuilt Photoshop, Premiere, and Illustrator using Claude Opus 5.5 and Rust.
Seven apps, zero subscription fees, completely open source.
Yeah, software giants ain't going to like this one bit.
Source: Gizmodo / Writer: Bri
@heyclairelin That's not a good strategy because each additional post per day gets less of a push from the algorithm.
I saw somebody with 60,000 followers say to follow this advice:
• 5 posts per day
• 1 article per day
• 50 comments per day
BREAKING STUDY: Nattokinase Breaks Down SPIKE PROTEIN, AMYLOID MICROCLOTS, BLOOD CLOTS, and SHRINKS ARTERIAL PLAQUE
We assembled DECADES of evidence to uncover the powerful MULTI-TARGET EFFECTS of nattokinase:
- Degrades spike protein
- Breaks down harmful amyloid proteins
- Dissolves abnormal amyloid microclots
- Breaks down fibrin blood clots
- Boosts the body’s natural clot-dissolving system
- Shrinks arterial plaque
- Lowers blood pressure
- Reduces blood-clotting factors and platelet clumping
Our new paper, “Proteolytic Targets and Clinical Benefits of Oral Nattokinase: Spike Protein and Amyloid Degradation, Fibrinolysis, and Cardiovascular Risk Reduction,” was produced through a collaboration between The Wellness Company and the McCullough Foundation.
It represents one of the most comprehensive evaluations of nattokinase to date, uniquely integrating its proteolytic, cardiovascular, pharmacokinetic, amyloid, and spike-protein literature into a single paper.
After oral dosing, nattokinase-related activity shows up in human blood and changes clotting and clot-breakdown markers within hours.
Three independent labs have now shown that nattokinase-related enzymes can BREAK DOWN SPIKE PROTEIN in vitro—including purified nattokinase itself.
At higher doses, human imaging studies reported about a 36% SHRINKAGE in carotid artery plaque—suggesting the effective range may begin around 6,000 FU/day.
Randomized human trials also show modest BLOOD-PRESSURE reductions with nattokinase, with pooled decreases of about 3.5 mmHg systolic and 2.3 mmHg diastolic.
And in long-term population studies, higher natto intake was associated with a 25% LOWER RISK of cardiovascular death and a 32% LOWER RISK of stroke death.
Nattokinase has been well tolerated across human studies, with no notable adverse events reported across six randomized trials. Even 10,800 FU/day for 12 months was used in a large observational cohort without reported excess bleeding.
This inexpensive, orally available enzyme holds immense promise for cardiovascular risk reduction in the post-COVID era.
It now deserves large-scale clinical testing for cardiovascular risk reduction and other post-vaccination injury applications.
We plan to launch some of these studies shortly.
@twc_health@McCulloughFund@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly
En 1979, un joven aterrado por el mundo decidió encerrarse dentro de una máquina y componer una obra maestra sobre el aislamiento. Ese pulso mecánico que inventó aquella noche terminó definiendo el futuro del pop electrónico...
Chinese streamer Fanqie Jiang Ye found an interesting way to get donations from viewers, charging $7.50 to make her spin 😭
- many viewers repeated the donation multiple times in a row causing her to spin nonstop.
@PleistosceneLyf Fortunately there are some great doctors out there to balance things out.
I once heard someone say that doctors are a bit like shoes. You might have to try a few before you find one that's comfortable.